President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Clinical Research50-Year Medalist Study
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

Jennifer K. Sun, M.D, M.P.H.

Specialty

Ophthalmology

Special
Interests

Diabetic Retinopathy

Teaching
Appointment

Harvard Medical

Medical School

Harvard Medical School/ BWH

Residency

Massachusetts Eye & Ear Infirmary

Fellowship

Mass Eye and Ear Infirmary

Certification

Ophthalmology

Bio
Dr. Jennifer Sun, an Associate Professor in the Harvard Department of Ophthalmology, graduated from Harvard College and Harvard Medical School, and completed Ophthalmology Residency and a Vitreoretinal Surgical Fellowship at the Massachusetts Eye and Ear Infirmary.  From 2005-2009, she participated in the Harvard Vision Clinical Scientist K12 program and received a Masters in Public Health in 2007 at the Harvard School of Public Health.  Since 2005, Dr. Sun has served as Chief of the Center for Clinical Eye Research and Trials of the Beetham Eye Institute, Joslin Diabetes Center.  She is the Chair of the DRCR.net (Diabetic Retinopathy Clinical Research Network) and previously served as the DRCR.net nationwide Protocol Working Investigator from 2010-2017.  From 2012-2104, she served as one of three Vice Chairs for the Network.  She is also a member of the DRCR.net’s Operations Group and Executive Committee. Dr. Sun has chaired 5 nationwide, multicenter clinical studies, including the DME FOUND Study (Diabetic Macular Edema Found by OCT Utilization at Non-Ophthalmic Diabetes care visits) evaluating the use of point-of-care noninvasive retinal imaging at primary diabetes care visits to identify patients at risk for vision loss from diabetic macular edema and a phase 1 trial of an intravitreous plasma kallikrein inhibitor for diabetic macular edema.  She served as the first nationwide Protocol Chair of both the DRCR.net Ultrawide Field Imaging Study (Protocol AA) and the DRCR.net Prevention of Vision Threatening Complications in Eyes at High Risk through Anti-VEGF Treatment (Protocol W) Study. Dr. Sun is the CME Editor for JAMA Ophthalmology and was the Section Editor for the Microvascular Complications: Retinopathy section of Current Diabetes Reports from 2008-2017. Her recent publications have included articles in both the New England Journal of Medicine and JAMA.  She received the 2008 ARVO/Alcon Early Career Clinician-Scientist Research Award and was recognized in 2016 with the Research to Prevent Blindness Physician-Scientist Award.  Her research projects include the search for protective factors against retinal complications in diabetes.  She also leads active studies identifying biomarkers of functional and anatomic outcomes in diabetic retinopathy and diabetic macular edema through utilization of advanced imaging techniques such as adaptive optics scanning laser ophthalmoscopy and spectral domain optical coherence tomography angiography. 

Jennifer K. Sun